SRC and hepatocellular carcinoma: Honokiol was also found to be involved in the inhibition of STAT3 in HCC cells through the inhibition of activation of upstream kinases c-Src, Janus-activated kinase 1 and Janus-activated kinase 2, when used in combination with common chemotherapies [36].